Description: CVS Health announced that its Board of Directors has elected President and CEO David Joyner as Chair of the Board, effective January 1, 2026, with current Executive Chair Roger Farah remaining on the Board and Michael Mahoney continuing as Lead Independent Director. This move consolidates board and executive leadership under Joyner, reflecting board confidence in his healthcare expertise and recent operational improvements since his appointment as CEO in October 2024. We’ll examine how the...

Description: This healthcare stock has struggled this year, but things are suddenly looking up.

Description: CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.

Description: Over the past year, CVS stock has outpaced the healthcare sector, garnering positive analyst sentiment and demonstrating sustained momentum.

Description: CVS Health (CVS) shares have been moving recently, capturing the attention of investors curious about what might be driving this latest price activity. The stock has witnessed some shifts over the past month, which has sparked ongoing conversation around the company’s valuation and growth outlook. See our latest analysis for CVS Health. CVS Health’s share price has picked up steam lately, gaining over 10% in the last 90 days and notching a sharp 4.3% rise this week alone. While it is still...

Description: CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Description: CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

Description: CVS Health stock has seen its consensus analyst price target edge down slightly from $91.52 to $91.48, a reflection of tempered optimism following recent earnings. Analysts cite a mix of upbeat and cautious factors shaping their outlooks; the modest adjustment captures both lingering industry challenges and growing confidence in the company’s execution. Stay tuned to learn how you can keep informed on further shifts in analyst sentiment as the narrative for CVS Health continues to...

Description: CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.

Description: Taxes and inflation are packing a one-two punch.

Description: Healthcare politics and investing might as well be living in alternate universes. President Trump and some Republicans have been describing Obamacare as a gravy train for insurers. Trump’s latest broadside slammed “big, fat, rich insurance companies who have made trillions,” and he urged Congress to send healthcare subsidies directly to patients instead.

Description: Valuations don't usually matter — until they do. And suddenly some S&P 500 investors seem to be paying at least some attention.

Description: If you have ever wondered whether CVS Health could be a hidden gem or just fairly priced, you are not alone. Let's break down whether the stock deserves a spot on your radar. Over the past year, CVS shares have climbed an impressive 38.9%, with an even more dramatic YTD surge of 72.0%. The last month has seen a pullback of 8.4%. Much of this recent movement came after CVS announced its expanded partnership with a major insurer and a handful of strategic healthcare acquisitions. These moves...

Description: The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

Description: CVS Health® (NYSE: CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Board, effective January 1, 2026. Following the effective date of this appointment, Michael Mahoney will continue to serve as the Board's Lead Independent Director, and Roger Farah, who is currently serving as Executive Chair of the Board, will continue to serve on the Board.

Description: CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.

Description: CVS Pharmacy® today announced the launch of Joyward™, a new line of decor, gifts and more to celebrate the joy of every season.

Description: Over the past decade, pharmacy giant Walgreens, with over 8,000 stores nationwide, has struggled financially due to several factors. The company’s finances have been impacted by opioid-related claims and litigation settlements, costing it billions of dollars. Walgreens has also been affected by ...

Description: CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Description: Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience.

Description: UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer expressed his thoughts on. A caller asked for Cramer’s opinion of the stock, and he replied: “I’m a buyer. What happened in UnitedHealth, where they did some, where there was some chicanery, seems to be the, the authorities don’t seem to be looking at […]

Description: TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.

Description: CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.

Description: CVS Health Corporation (NYSE:CVS) is one of the best blue-chip stocks to buy now. On November 3, 2025, TD Cowen lifted its price target on the stock to $100 from $99, while keeping a Buy rating. The move followed management’s updated guidance, which narrowed the expected GAAP diluted loss per share to between $0.24 and […]

Description: Insights from Glenview Capital Management's Third Quarter 2025 13F Filing

Description: SAP gains momentum as cloud ERP growth, strong pipelines and AI-driven solutions anchor its latest featured research report.

Description: CVS Health recently reported a robust third quarter, surpassing analyst expectations with a significant increase in adjusted earnings per share and raising full-year 2025 guidance, driven by strong performance in key segments and successful integration of acquired Rite Aid and Bartell Drugs prescription files. These developments reflect CVS Health's renewed operational momentum under new leadership, as the company sharpens its focus on more profitable growth areas and leverages its expanded...

Description: Eli Lilly Dumps CVS Health Plan After Coverage Rift on Weight-Loss Drugs

Description: Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index gaining 1.6% and th

Description: UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.

Description: These companies are demonstrating their ability to deal with significant business risks.

Description: Last year was a bad one for these stocks, but buying them on weakness would have proven to be a great move for investors.

Description: Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Infineon Technologies (IFX.DE, IFNNY) raising its revenue guidance on AI data center demand, Chevron (CVX) choosing West Texas as the site of its first AI data center project, and Eli Lilly (LLY) reportedly dropping CVS Health's (CVS) drug plan from employee coverage. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.

Description: CVS raises its full-year EPS outlook after a strong quarter, driven by gains across all segments and solid pharmacy growth.

Description: The company replaced its CEO last year, and the turnaround has been going well.

Description: Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.

Description: CVS Health (CVS) recently posted a net loss for the third quarter, cut full-year earnings guidance, and reported a major goodwill impairment. These developments have investors rethinking the company’s near-term outlook and business momentum. See our latest analysis for CVS Health. While CVS Health’s hefty goodwill impairment and reduced earnings outlook have weighed on sentiment, the 20.6% share price return over the last 90 days suggests some investors see value after a tough stretch. Total...

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide financial guidance for 2025 and 2026.

Description: TRIP announces a $40 million funding round – led by high-profile names such as Joe Jonas, Alessandra Ambrosio, Paul Wesley, Ashley Graham, and consumer fund Coefficient Capital. TRIP, the fastest growing drinks brand in the US this year (Spins) is on track to deliver $100 million in annual revenue this year and is predicted to reach $200 million in 2026.

Description: CVS Health stock has recently seen its Fair Value Estimate rise from $86.20 to $91.52, reflecting increased confidence in the company's near-term earnings outlook. This price target adjustment follows strong quarterly results and sector trends, which indicate both momentum and ongoing market challenges. Stay tuned for strategies on how to keep up with the evolving narrative around CVS Health’s valuation and prospects. Analyst Price Targets don't always capture the full story. Head over to our...

Description: Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.

Description: President Donald Trump wrote that "hundreds of billions" in federal funding should be shifted from "money sucking" health insurers to the public.

Description: The company's prospects are looking up.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently shared thoughts on. Cramer discussed the company’s “reinvention,” as he said: “Sadly, this tale of reinvention doesn’t happen very often, but when it does, I celebrate it. For example, I really like what David Joyner’s doing with the turnaround at CVS. Value creation, […]

Description: Wondering if CVS Health is a true bargain or just another healthcare stock? You're in the right place to find out what the numbers actually say about its value. Despite some short-term ups and downs, with a 2.2% gain over the past month and a significant 32.9% rally over the last year, CVS Health has caught the eye of both growth seekers and value hunters. Recent headlines highlight CVS’s ongoing push into primary care through acquisitions and collaborative healthcare initiatives. This has...

Description: The boss of the London Stock Exchange's parent company is to urge Rachel Reeves to take fresh steps in the budget to incentivise as much as £100bn of additional investment by UK pension funds into the domestic stock market. Sky News has learnt that a letter from David Schwimmer, the LSEG chief executive, has amassed more than 250 signatures from companies including pubs group Mitchells & Butlers, construction firm Kier and fresh food producer Bakkavor.

Description: Teladoc Health's Q3 results beat estimates, but revenues dipped and losses widened, attributed to soft performance at BetterHelp.

Description: CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Description: Candy Ventures Sarl, a portfolio of companies founded by Nick Candy, took legal action against Dutch businessman Robert Bonnier and his firm.

Description: CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail pharmacy, market share gains, and early progress on Aetna’s operational turnaround. CEO David Joyner emphasized that CVS’s “diversified business and progress on becoming the most trusted health care company” helped offset reimbursement pressures and challenges in Health Care Delivery. The company’s

Description: The new hires will report to Daniel Heaf, chief executive officer of Bath & Body Works.

Description: Maly Bernstein, who spent four years leading the Macy’s, Inc. banner, has been named chief commercial officer.

Description: Some financial successes are enough to impress even the world's richest man.

Description: CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America. The in-store campaign, hosted at CVS Pharmacy locations nationwide, gave customers a simple and impactful way to contribute to the movement to end hunger in their own communities. CVS Health has also committed over $2 million in 2025 to address food insecurity, continuing a long history of suppo

Description: CVS Health (CVS) reported a net profit margin of just 0.1%, a notable drop from last year’s 1.4%. Over the last five years, the company’s earnings have declined by 12.5% annually, and the most recent 12 months were hit by a one-off $6.3 billion loss. Despite these setbacks, analysts expect earnings to rebound sharply, forecasting 40.76% annual growth going forward. Revenue is expected to rise 4.6% per year, trailing the broader U.S. market’s pace. Investors will be weighing the promise of...

Description: A strong quarter clouded by one costly accounting charge.

Description: Gilead Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine. Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June. Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.

Description: The bond sale comes a day after Chief Executive Officer Mark Zuckerberg warned that the company would spend even more aggressively on artificial intelligence in the coming year. Morgan Stanley expects big tech companies known as hyperscalers to spend about $3 trillion on infrastructure like data centers between now and the end of 2028, with roughly half of that likely financed through the corporations’ cash flows. Thursday’s bond sale is the biggest high-grade note offering since 2023, when Pfizer Inc. sold $31 billion of debt.

Description: Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health Care Delivery business, which overshadowed otherwise strong third-quarter results.

Description: Investing.com -- Meta Platforms Inc. has received orders of about $125 billion for its corporate bond sale, setting a new record for such an offering, according to a Bloomberg report released Thursday. The announcement of the bond offering sent the company’s shares as much as 13% during Thursday session.

Description: CVS Health's (CVS) "strong" Q3 performance reinforces the company's position as a leading Medicare A

Description: The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

Description: It's a turnaround for the 'broke' generation.

Description: Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was 18.3% above analysts’ consensus estimates.

Description: CVS Health Corporation (NYSE:CVS) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. CVS Health Corporation (NYSE:CVS) is a diver⁠sif⁠ie​d healthcare c‌ompany that runs pharmacies and retail stor‍es whil‌e offering various health services, such as prescription management, vaccinations, and di‌agnostic testing. On October 24⁠, UBS‌ increa⁠sed its pr⁠ice targ‌et […]

Description: Cigna has outperformed peers as the managed-care industry faces policy challenges. Affordable Care Act subsidies are set to expire and premiums for next year are up 26%.

Description: CVS Health announced a $5.7 billion write-down primarily related to Oak Street Health, an operator of medical clinics servicing the elderly, on Wednesday as part of its third-quarter earnings release. Investors may recall that CVS—a drugstore operator, health insurer, drug benefits, and health services provider—acquired Oak Street in a $10.7 billion all-cash deal in 2023. Oak Hill operated 239 medical clinics, or what the company calls value-based primary care centers, at the end of 2024 and served 500,000 patients last year.

Description: On Tuesday, UnitedHealth Group Chief Executive Stephen Hemsley told investors the company is “positioning for durable and accelerating growth in 2026 and beyond.” One way it is doing that: cutting its Medicare business down to size. Bobby Hunter, who oversees UnitedHealth care’s government programs, said the insurer expects its Medicare membership to fall by about one million members next year.

Description: All three major US stock indexes were up in late-morning trading on Wednesday, as investors look ahe

Description: CVS Health (CVS) stock is in focus after the company reported record-high revenue and lifted its full-year outlook. Grey Ghost Capital healthcare investor and Tenet Healthcare (THC) board member, Meghan Fitzgerald, joins Market Catalysts to discuss the earnings print and CVS's ongoing turnaround efforts. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Description: CVS Health (NYSE: CVS) reported third-quarter results this morning that beat adjusted earnings expectations but delivered a mixed message on operations and cash flow. Adjusted EPS came in at $1.60, well above the $1.37 consensus estimate. Revenue reached $102.87 billion, topping the $98.85 billion expectation and books sales grew 7.8% year over year as all ... CVS Posts Strong Q3 Earnings, but Shares Show Little Movement

Description: CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.

Description: CVS Health stock has been on the mend somewhat after falling from its 2022 high, but questions remain about its ongoing recovery.

Description: The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.

Description: CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter. The company said Wednesday that it filled more prescriptions at drugstores, partially due to added business from customers of the defunct Rite Aid chain. CVS Health recently said it will close 16 underperforming clinics early next year.

Description: An increase in the deduction limit sounds like great news for high earners — but take cover, because a high-speed tax penalty is headed your way.

Description: CVS Health (CVS) delivered earnings and revenue surprises of +17.65% and +4.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: The main US stock measures were pointing higher in Wednesday's premarket activity as traders await t

Description: Investing.com - CVS Health lifted its annual profit outlook, but flagged a $5.7 billion charge linked to an impairment test which showed that the fair value of its struggling health care delivery division was below its carrying value.

Description: Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ consensus estimates.

Description: WOONSOCKET, R.I. (AP) — CVS Health Corporation (CVS) on Wednesday reported a loss of $3.98 billion in its third quarter. On a per-share basis, the Woonsocket, Rhode Island-based company said it had a loss of $3.13. Earnings, adjusted for one-time gains and costs, were $1.60 per share.

Description: The healthcare giant beat Wall Street expectations in the third quarter, but reported a net loss after recording a $5.7 billion charge linked primarily to decelerating clinic growth at Oak Street Health.

Description: CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2025.

Description: CV S Health stock has been on the mend somewhat after falling from its 2022 high, but questions remain about its ongoing recovery.

Description: CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.

Description: Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market hours. Here’s what investors should know.

Description: CVS Health Corporation (NYSE:CVS) is one of the stocks in focus in the game plan Jim Cramer shared. Cramer made some positive comments on the stock. He said: “Next, Wednesday got me trembling in anticipation. Why? Well, this morning has a sure winner in CVS, at least from my point of view. Now, I’m betting […]

Description: CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.

Description: As it turns out, there's lots you can learn from teachers.

Description: Recent updates have brought a modest increase in CVS Health’s Fair Value Estimate, rising to $86.20 from $83.79, and a slight decrease in the discount rate to 7.19 percent from 7.24 percent. Analysts attribute these changes to renewed confidence in the company’s execution, improved visibility in key Medicare metrics, and cautious optimism about the recovery in managed care margins. Stay tuned to discover how investors can stay ahead as expectations shift as the outlook for CVS Health stock...

Description: Don't let your money languish in an account that doesn't give you anything back.

Description: You don't need to turn to prospecting to see the benefits the shiny metal can bring.

Description: Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Description: In the latest trading session, CVS Health (CVS) closed at $81.07, marking a -1.15% move from the previous day.

Description: Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Description: There are some economic factors the boomer finance expert may be overlooking.

Description: CVS Health (CVS) shares slipped after the company posted earnings that initially looked solid. However, management’s comments on persistent Medicaid margin pressures quickly became the focus. Investors are now scrutinizing the outlook for its government insurance business. See our latest analysis for CVS Health. While CVS Health’s latest quarter was overshadowed by tough Medicaid headlines, its 39.6% share price surge over the last 90 days and a strong 85.5% gain year-to-date suggest momentum...

Description: CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Description: InnerScope Hearing Technologies Inc. (OTC: INND), a publicly traded innovator in hearing health ("InnerScope"), today announced its pivotal role in the pending acquisition of OTCHealth Inc. ("OTCHealth") by Ainnova Tech Inc. ("Ainnova"), a global leader in AI-powered early disease detection. This transaction marks a major milestone for InnerScope, as it leverages its established retail distribution agreements and technology pipeline to drive growth and innovation across the U.S. and global healt

Description: HOUSTON, TX / ACCESS Newswire / October 22, 2025 / Ainnova Tech Inc., (" Ainnova ") a global leader in artificial intelligence for early disease detection, today announced the signing of a Letter of Intent to acquire OTCHealth Inc., (" OTCHealth ") ...

Description: CVS Health is slated to release its fiscal third-quarter earnings later this month, and analysts are anticipating a notable double-digit growth in profits.

Description: CVS vs. HQY: Which Stock Is the Better Value Option?

Description: The health insurer’s results looked strong at first glance, but the stock fell as management discussed margins in its Medicaid business.

Description: Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Description: SAN FRANCISCO, October 21, 2025--Rune Labs, the leader in precision medicine for neurology, today announced the appointment of Adam Pellegrini as an independent member of its Board of Directors. Pellegrini is a recognized leader in AI-driven digital health, with more than two decades of experience building and scaling platforms that bridge technology, patients, and healthcare systems. His background spans executive roles at Kaia Health, Jasper Health, CVS Health, Fitbit, Walgreens Boots Alliance

Description: Costco (NASDAQ:COST), the warehouse club best known for its bulk bargains and $1.50 hot dogs, is expanding its pharmacy into fast-growing weight-loss drug market. The company is now selling Ozempic and Wegovy — two of the most in-demand prescription ...

Description: CVS Health (CVS) closed at $82.52 in the latest trading session, marking a +1.41% move from the prior day.

Description: Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.

Description: O's focus on non-discretionary tenants drives steady cash flow and keeps its portfolio nearly full even in uncertain markets.

Description: DHR gears up for Q3 results with steady earnings estimates and mixed segment trends across Life Sciences, Biotechnology and Diagnostics.

Description: CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.